Decreasing the need for transfusion: Infant cardiac surgery using hemodilution and recombinant factor VIIa

Pediatric Cardiology

Volumn 34, Issue 1, 2013, Pages 119-124

  Winch, Peter D ^a   Naguib, Aymen N ^a   Bradshaw, Jacob R ^b   Galantowicz, Mark ^a   Tobias, Joseph D ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Decrease transfusion; Neonatal congenital cardiac surgery; Recombinant factor VIIa

Indexed keywords

ACID CITRATE DEXTROSE; CALCIUM CHLORIDE; FIBRINOGEN; NORMOSOL; PLASMA PROTEIN; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ACUTE NORMOVOLEMIC HEMODILUTION; ARTICLE; BLEEDING; BLOOD ALLOTRANSFUSION; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COLLOID; CRYSTALLOID; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; GROUPS BY AGE; HEMODILUTION; HEMOSTASIS; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; OPEN HEART SURGERY; PEDIATRIC SURGERY; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; FACTOR VIIA; HEMODILUTION; HUMANS; INFANT; INFANT, NEWBORN; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84872616248     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0398-1     Document Type: Article

References (23)

1. Anderson L (2010) Blood conservation in cardiac surgery. J Perioper Pract 20:436-439
2. Billio A, Pescosta N, Rosanelli C, Amaddii G, Fontanella F, Coser P (1997) Successful short-term oral surgery prophylaxis with rFVIIa in severe congenital factor VII deficiency. Blood Coagul Fibrinolysis 8:249-250
3. Chuansumrit A, Teeraratkul S, Wanichkul S et al (2010) Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients. Blood Coagul Fibrinolysis 21:354-362
4. Cote CJ, Drop LJ, Hoaglin DC, Daniels AL, Young ET (1988) Ionized hypocalcemia after fresh frozen plasma administration to thermally injured children: Effects of infusion rate, duration, and treatment with calcium chloride. Anesth Analg 67:152-160
5. Ekert H, Brizard C, Eyers R, Cochrane A, Henning R (2006) Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or decrease blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 17:389-395
6. Friedenberg WR, Myers WO, Plotka ED et al (1978) Platelet dysfunction associated with cardiopulmonary bypass. Ann Thorac Surg 25:298-305
7. Hedner U (2001) Recombinant factor VIIa (Novoseven) as a hemostatic agent. Semin Hematol 38:43-47
8. Hendriks HG, van der Maaten JM, de Wolf J, Waterbolk TW, Slooff MJ, van der Meer J (2001) An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 93:287-289
9. Herbertson M, Kenet G (2008) Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children. Haemophilia 14:753-762
10. Karsies TJ, Nicol KK, Galantowicz ME, Stephens JA, Kerlin BA (2010) Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience. Ann Thorac Surg 89:570-576
11. Kessler C (2002) Haemorrhagic complications of thrombocytopenia and oral anticoagulation: Is there a role for recombinant activated factor VII? Intensive Care Med 28:S228-S334
12. Mathew P, Young G (2006) Recombinant factor VIIa in paediatric bleeding disorders - a 2006 review. Haemophilia 12:457-472
13. Monroe DM, Hoffman M, Oliver JA, Roberts HR (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-547
14. Naguib AN, Winch P, Schwartz L et al (2010) Anesthetic management of the hybrid stage 1 procedure for hypoplastic left heart syndrome (HLHS). Paediatr Anaesth 20:38-46
15. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295:293-298
16. Olshove VF Jr, Preston T, Gomez D, Phillips A, Galantowicz M (2010) Perfusion techniques toward bloodless pediatric open heart surgery. J Extra Corpor Technol 42:122-127
17. Razon Y, Erez E, Vidne B et al (2005) Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease. Paediatr Anaesth 15:235-240
18. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR (1991) Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 75:563-570
19. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R (1991) Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 75:388-393
20. Rousou JA, Engelman RM, Flack JE 3rd, Deaton DW, Garb JL, Owen SG (1999) The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg 7:228-235
21. Tobias JD, Groeper K, Berkenbosch JW (2003) Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. South Med J 96:12-16
22. Veldman A, Josef J, Fischer D, Volk WR (2006) A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life. Pediatr Crit Care Med 7:34-39
23. Young G, McDaniel M, Nugent DJ (2005) Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors. Haemophilia 11:203-207